173 related articles for article (PubMed ID: 26318142)
1. Inhibitory effects of a novel cationic dodecapeptide [CL(14-25)] derived from cyanate lyase of rice on endotoxic activities of LPSs from Escherichia coli and periodontopathic Aggregatibacter actinomycetemcomitans.
Takayama S; Hashimoto K; Kokubu E; Taniguchi M; Tajima K; Ochiai A; Saitoh E; Saito A; Ishihara K; Kato T
Microb Pathog; 2016 May; 94():2-11. PubMed ID: 26318142
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-neutralizing activity and mechanism of action of a cationic α-helical antimicrobial octadecapeptide derived from α-amylase of rice.
Taniguchi M; Ochiai A; Matsushima K; Tajima K; Kato T; Saitoh E; Tanaka T
Peptides; 2016 Jan; 75():101-8. PubMed ID: 26643956
[TBL] [Abstract][Full Text] [Related]
3. Effects of arginine and leucine substitutions on anti-endotoxic activities and mechanisms of action of cationic and amphipathic antimicrobial octadecapeptide from rice α-amylase.
Taniguchi M; Ochiai A; Toyoda R; Sato T; Saitoh E; Kato T; Tanaka T
J Pept Sci; 2017 Mar; 23(3):252-260. PubMed ID: 28185358
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide production by a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans.
Sosroseno W; Barid I; Herminajeng E; Susilowati H
Oral Microbiol Immunol; 2002 Apr; 17(2):72-8. PubMed ID: 11929552
[TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
6. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide.
Swierzko AS; Kirikae T; Kirikae F; Hirata M; Cedzynski M; Ziolkowski A; Hirai Y; Kusumoto S; Yokochi T; Nakano M
J Med Microbiol; 2000 Feb; 49(2):127-138. PubMed ID: 10670563
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
Lin QP; Zhou LF; Li NN; Chen YQ; Li BC; Cai YF; Zhang SQ
Eur J Pharmacol; 2008 Oct; 596(1-3):160-5. PubMed ID: 18789317
[TBL] [Abstract][Full Text] [Related]
8. Effect of substituting arginine and lysine with alanine on antimicrobial activity and the mechanism of action of a cationic dodecapeptide (CL(14-25)), a partial sequence of cyanate lyase from rice.
Taniguchi M; Takahashi N; Takayanagi T; Ikeda A; Ishiyama Y; Saitoh E; Kato T; Ochiai A; Tanaka T
Biopolymers; 2014 Jan; 102(1):58-68. PubMed ID: 23982951
[TBL] [Abstract][Full Text] [Related]
9. LPS from Actinobacillus actinomycetemcomitans and production of nitric oxide in murine macrophages J774.
Blix IJ; Helgeland K
Eur J Oral Sci; 1998 Feb; 106(1):576-81. PubMed ID: 9527358
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity and mechanism of action of a novel cationic α-helical dodecapeptide, a partial sequence of cyanate lyase from rice.
Takei N; Takahashi N; Takayanagi T; Ikeda A; Hashimoto K; Takagi M; Hamada T; Saitoh E; Ochiai A; Tanaka T; Taniguchi M
Peptides; 2013 Apr; 42():55-62. PubMed ID: 23270672
[TBL] [Abstract][Full Text] [Related]
11. Pro-atherogenic properties of lipopolysaccharide from the periodontal pathogen Actinobacillus actinomycetemcomitans.
Lakio L; Lehto M; Tuomainen AM; Jauhiainen M; Malle E; Asikainen S; Pussinen PJ
J Endotoxin Res; 2006; 12(1):57-64. PubMed ID: 16420744
[TBL] [Abstract][Full Text] [Related]
12. The anti-endotoxic effects of the KSL-W decapeptide on Escherichia coli O55:B5 and various oral lipopolysaccharides.
Dixon DR; Karimi-Naser L; Darveau RP; Leung KP
J Periodontal Res; 2008 Aug; 43(4):422-30. PubMed ID: 18503516
[TBL] [Abstract][Full Text] [Related]
13. The effects of Porphyromonas gingivalis LPS and Actinobacillus actinomycetemcomitans LPS on human dendritic cells in vitro, and in a mouse model in vivo.
Mahanonda R; Pothiraksanon P; Sa-Ard-Iam N; Yamazaki K; Schifferle RE; Hirunpetcharat C; Yongvanichit K; Pichyangkul S
Asian Pac J Allergy Immunol; 2006 Dec; 24(4):223-8. PubMed ID: 17348245
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages.
Kanno S; Shouji A; Tomizawa A; Hiura T; Osanai Y; Ujibe M; Obara Y; Nakahata N; Ishikawa M
Life Sci; 2006 Jan; 78(7):673-81. PubMed ID: 16137700
[TBL] [Abstract][Full Text] [Related]
17. Enterococcus faecalis lipoteichoic acid suppresses Aggregatibacter actinomycetemcomitans lipopolysaccharide-induced IL-8 expression in human periodontal ligament cells.
Im J; Baik JE; Kim KW; Kang SS; Jeon JH; Park OJ; Kim HY; Kum KY; Yun CH; Han SH
Int Immunol; 2015 Aug; 27(8):381-91. PubMed ID: 25840438
[TBL] [Abstract][Full Text] [Related]
18. Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts.
Patil C; Rossa C; Kirkwood KL
Oral Microbiol Immunol; 2006 Dec; 21(6):392-8. PubMed ID: 17064398
[TBL] [Abstract][Full Text] [Related]
19. Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli.
Kirikae T; Kirikae F; Saito S; Tominaga K; Tamura H; Uemura Y; Yokochi T; Nakano M
Antimicrob Agents Chemother; 1998 May; 42(5):1015-21. PubMed ID: 9593119
[TBL] [Abstract][Full Text] [Related]
20. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells.
Tanamoto K; Azumi S
J Immunol; 2000 Mar; 164(6):3149-56. PubMed ID: 10706705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
